Home > Financial Ratios > PIRAMAL PHARMA

PIRAMAL PHARMA
Cash Earnings per Share (CEPS)

    Back to All Ratios
PIRAMAL PHARMA is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for PIRAMAL PHARMA
Please provide your vote to see the results

PIRAMAL PHARMA Last 5 Year Cash Earnings per Share (CEPS) History

[Consolidated]

Mar2023Mar2022Mar2021
   CEPS(Rs) 4.118.1113.88

What is the latest Cash Earnings per Share (CEPS) ratio of PIRAMAL PHARMA ?

The latest Cash Earnings per Share (CEPS) ratio of PIRAMAL PHARMA is 4.11 based on Mar2023 Consolidated results.
Year Cash Earnings per Share (CEPS)
Mar20234.11
Mar20228.11
Mar202113.88

How is Cash Earnings per Share (CEPS) of PIRAMAL PHARMA Trending?

Years Cash Earnings per Share (CEPS) % Change
Mar2023 4.11
-49.32
Mar2022 8.11
-41.57
Mar2021 13.88 -

Other Financial Ratios of PIRAMAL PHARMA


Compare Cash Earnings per Share (CEPS) ratio of peers of PIRAMAL PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
PIRAMAL PHARMA ₹19,836.9 Cr 2% 5.4% 107.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹351,467.0 Cr -4.9% -2.6% 54% Stock Analytics
CIPLA ₹119,470.0 Cr -0.1% 5% 57.6% Stock Analytics
DIVIS LABORATORIES ₹116,563.0 Cr 8.1% 9.1% 25.6% Stock Analytics
ZYDUS LIFESCIENCES ₹105,690.0 Cr -2.4% 10.8% 110% Stock Analytics
DR REDDYS LABORATORIES ₹99,351.1 Cr 1.4% -4.8% 30.2% Stock Analytics


PIRAMAL PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
PIRAMAL PHARMA

2%

5.4%

107.1%

SENSEX

1.7%

1.1%

21.3%


You may also like the below Video Courses